MarginScan™
CPRIT Award
NovaScan has been awarded a $3.7 million, non-dilutive grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to support expansion of MarginScan™ into breast excision assessment and subsequent FDA clearance.
The award reflects CPRIT's rigorous scientific and commercial diligence and underscores the unmet need for improved intraoperative margin assessment in breast-conserving surgery.